{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:38:33Z","timestamp":1772768313398,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bmcl.2021.128087","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T10:49:51Z","timestamp":1620298191000},"page":"128087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Design, synthesis and biological evaluation of a series of iron and copper chelating deferiprone derivatives as new agents active against Candida albicans"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5740-6499","authenticated-orcid":false,"given":"Martina","family":"Bortolami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5972-851X","authenticated-orcid":false,"given":"Fabiana","family":"Pandolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0158-5816","authenticated-orcid":false,"given":"Antonella","family":"Messore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3673-6509","authenticated-orcid":false,"given":"Marta","family":"Feroci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Di Santo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Costi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Cascarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4321-4626","authenticated-orcid":false,"given":"Giovanna","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2006-7005","authenticated-orcid":false,"given":"Luigi","family":"Scipione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.128087_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2019.04.001","article-title":"Candida albicans biofilm growth and dispersal: contributions to pathogenesis","volume":"52","author":"Wall","year":"2019","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128087_b0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jac\/dkz400","article-title":"Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans","volume":"75","author":"Nishimoto","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128087_b0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11046-020-00445-w","article-title":"Candida biofilms: an update on developmental mechanisms and therapeutic challenges","volume":"185","author":"de Barros","year":"2020","journal-title":"Mycopathologia"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128087_b0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/microorganisms8020154","article-title":"Candida albicans antifungal resistance and tolerance in bloodstream infections: the triad yeast-host-antifungal","volume":"8","author":"Costa-de-Oliveira","year":"2020","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128087_b0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/jof6010023","article-title":"An overview on conventional and non-conventional therapeutic approaches for the treatment of candidiasis and underlying resistance mechanisms in clinical strains","volume":"6","author":"Salazar","year":"2020","journal-title":"J Fungi"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128087_b0030","doi-asserted-by":"crossref","first-page":"FSO440","DOI":"10.2144\/fsoa-2019-0027","article-title":"Virulence and biofilms as promising targets in developing antipathogenic drugs against candidiasis","volume":"6","author":"Ahmad Khan","year":"2020","journal-title":"Future Sci OA"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128087_b0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.chom.2011.07.005","article-title":"An iron homeostasis regulatory circuit with reciprocal roles in Candida albicans commensalism and pathogenesis","volume":"10","author":"Chen","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128087_b0040","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1365-2958.2004.04214.x","article-title":"Regulatory networks affected by iron availability in Candida albicans","volume":"53","author":"Lan","year":"2004","journal-title":"Mol Microbiol"},{"issue":"5468","key":"10.1016\/j.bmcl.2021.128087_b0045","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.288.5468.1062","article-title":"A high-affinity iron permease essential for Candida albicans virulence","volume":"288","author":"Ramanan","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128087_b0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/mmi.12659","article-title":"Iron-responsive chromatin remodelling and MAPK signalling enhance adhesion in Candida albicans","volume":"93","author":"Puri","year":"2014","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmcl.2021.128087_b0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2180-13-16","article-title":"Involvement of the mitogen activated protein kinase Hog1p in the response of Candida albicans to iron availability","volume":"13","author":"Kaba","year":"2013","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.bmcl.2021.128087_b0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinorgbio.2016.04.018","article-title":"Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents","volume":"160","author":"Workman","year":"2016","journal-title":"J Inorg Biochem"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128087_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1574-6968.2010.01956.x","article-title":"Effect of trace iron levels and iron withdrawal by chelation on the growth of Candida albicans and Candida vini","volume":"307","author":"Holbein","year":"2010","journal-title":"FEMS Microbiol Lett"},{"issue":"8","key":"10.1016\/j.bmcl.2021.128087_b0070","doi-asserted-by":"crossref","first-page":"e02576","DOI":"10.1128\/AAC.02576-17","article-title":"Iron restriction to clinical isolates of Candida albicans by the novel chelator DIBI inhibits growth and increases sensitivity to azoles in vitro and in vivo in a murine model of experimental vaginitis","volume":"62","author":"Savage","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt B","key":"10.1016\/j.bmcl.2021.128087_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.fct.2018.04.014","article-title":"Synergistic effect of caffeic acid phenethyl ester with caspofungin against Candida albicans is mediated by disrupting iron homeostasis","volume":"116","author":"Sun","year":"2018","journal-title":"Food Chem Toxicol"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128087_b0080","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1128\/AAC.06017-11","article-title":"Potent synergistic effect of doxycycline with fluconazole against Candida albicans is mediated by interference with iron homeostasis","volume":"56","author":"Fiori","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.bmcl.2021.128087_b0085","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1128\/AAC.00653-06","article-title":"Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells","volume":"50","author":"Prasad","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128087_b0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7883\/yoken.64.292","article-title":"Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis","volume":"64","author":"Kobayashi","year":"2011","journal-title":"Jpn J Infect Dis"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128087_b0095","doi-asserted-by":"crossref","first-page":"e02152","DOI":"10.1128\/AAC.02152-18","article-title":"Iron chelator deferasirox reduces Candida albicans invasion of oral epithelial cells and infection levels in murine oropharyngeal candidiasis","volume":"63","author":"Puri","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128087_b0100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jac\/dkt398","article-title":"Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms","volume":"69","author":"Rane","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128087_b0105","first-page":"1413","article-title":"Evaluation of the antifungal effect of EDTA, a metal chelator agent, on Candida albicans biofilm","volume":"21","author":"Casalinuovo","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128087_b0110","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1038\/s41598-020-59750-5","article-title":"Gemini quaternary ammonium compound PMT12-BF4 inhibits Candida albicans via regulating iron homeostasis","volume":"10","author":"Hsu","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128087_b0115","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1067\/mlc.2001.113577","article-title":"Effect of metals on Candida albicans growth in the presence of chemical chelators and human abscess fluid","volume":"137","author":"Sohnle","year":"2001","journal-title":"J Lab Clin Med"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128087_b0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/acsinfecdis.7b00215","article-title":"Discovery of a novel dibromoquinoline compound exhibiting potent antifungal and antivirulence activity that targets metal ion homeostasis","volume":"4","author":"Mohammad","year":"2018","journal-title":"ACS Infect Dis"},{"issue":"8","key":"10.1016\/j.bmcl.2021.128087_b0125","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00775-020-01828-6","article-title":"A copper(II)-binding triazole derivative with ionophore properties is active against Candida spp","volume":"25","author":"Gaspar-Cordeiro","year":"2020","journal-title":"J Biol Inorg Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128087_b0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12866-020-01850-3","article-title":"The effects of clioquinol in morphogenesis, cell membrane and ion homeostasis in Candida albicans","volume":"20","author":"You","year":"2020","journal-title":"BMC Microbiol"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128087_b0135","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00775-020-01796-x","article-title":"Fluconazole analogues with metal-binding motifs impact metal-dependent processes and demonstrate antifungal activity in Candida albicans","volume":"25","author":"Hunsaker","year":"2020","journal-title":"J Biol Inorg Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2021.128087_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006350","article-title":"Metal chelation as a powerful strategy to probe cellular circuitry governing fungal drug resistance and morphogenesis","volume":"12","author":"Polvi","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1016\/j.bmcl.2021.128087_b0145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fcimb.2018.00286","article-title":"Promising antifungal targets against candida albicans based on ion homeostasis","volume":"8","author":"Li","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128087_b0150","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12275-013-3052-6","article-title":"Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha conversion of fluconazole resistant Candida albicans","volume":"51","author":"Abdelmegeed","year":"2013","journal-title":"J Microbiol"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128087_b0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1128\/AAC.48.1.41-47.2004","article-title":"Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans","volume":"48","author":"Alem","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128087_b0160","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bmc.2016.01.026","article-title":"In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp","volume":"24","author":"Rosato","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128087_b0165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.mycmed.2018.03.002","article-title":"Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole","volume":"28","author":"Kr\u00f3l","year":"2018","journal-title":"J Mycol Med"},{"key":"10.1016\/j.bmcl.2021.128087_b0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejps.2015.02.011","article-title":"Antimicrobial activity of ibuprofen: new perspectives on an \u201cOld\u201d non-antibiotic drug","volume":"71","author":"Obad","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128087_b0175","first-page":"DC20-22","article-title":"Ibuprofen-mediated reversal of fluconazole resistance in clinical isolates of Candida","volume":"9","author":"Sharma","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128087_b0180","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/AAC.05056-14","article-title":"Ibuprofen potentiates the in vivo antifungal activity of fluconazole against Candida albicans murine infection","volume":"59","author":"Costa-de-Oliveira","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128087_b0185","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1567-1364.2009.00504.x","article-title":"Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes","volume":"9","author":"Ricardo","year":"2009","journal-title":"FEMS Yeast Res"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128087_b0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1439-0507.2004.01052.x","article-title":"Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans","volume":"48","author":"Arai","year":"2005","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128087_b0195","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jac\/dki264","article-title":"Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry","volume":"56","author":"Pina-Vaz","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128087_b0200","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1099\/0022-1317-49-9-831","article-title":"Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species","volume":"49","author":"Pina-Vaz","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.bmcl.2021.128087_b0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejmech.2019.01.012","article-title":"Searching for new agents active against Candida albicans biofilm: A series of indole derivatives, design, synthesis and biological evaluation","volume":"165","author":"Pandolfi","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128087_b0210","doi-asserted-by":"crossref","unstructured":"Bortolami M., Pandolfi F., De Vita D., Carafa C., Messore A., Di Santo R., Feroci M., Costi R., Chiarotto I., Bagetta D., Alcaro S., Colone M., Stringaro A., Scipione L. New deferiprone derivatives as multi-functional cholinesterase inhibitors: design, synthesis and in vitro evaluation. Eur. J. Med. Chem. 2020, 198, 112350. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112350.","DOI":"10.1016\/j.ejmech.2020.112350"},{"key":"10.1016\/j.bmcl.2021.128087_b0215","first-page":"1","article-title":"Design, synthesis and evaluation of 3-hydroxypyridin-4-ones as inhibitors of catechol-O-methyltransferase","volume":"2020","author":"De Beer","year":"2020","journal-title":"Mol Divers"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128087_b0220","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ejmech.2007.07.011","article-title":"Basic 3-Hydroxypyridin-4-ones: Potential antimalarial agents","volume":"43","author":"Dehkordi","year":"2008","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128087_b0225","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.bmcl.2014.02.005","article-title":"Activity of caffeic acid derivatives against Candida albicans biofilm","volume":"24","author":"De Vita","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.128087_b0230","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"1\u20133","key":"10.1016\/j.bmcl.2021.128087_b0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmcl.2021.128087_b0240","first-page":"113","article-title":"Formation and stability of inorganic complexes in solution","volume":"9","author":"Job","year":"1928","journal-title":"Ann Chim"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128087_b0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1011117412693","article-title":"A practical guide for the determination of binding constants","volume":"39","author":"Hirose","year":"2001","journal-title":"J Incl Phenom Macrocycl Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128087_b0250","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11095-016-2069-z","article-title":"Alternative animal and non-animal models for drug discovery and development: bonus or burden?","volume":"34","author":"Freires","year":"2017","journal-title":"Pharm Res"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21003139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21003139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:39:43Z","timestamp":1760773183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21003139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":50,"alternative-id":["S0960894X21003139"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128087","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of a series of iron and copper chelating deferiprone derivatives as new agents active against Candida albicans","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128087"}}